Concepedia

Tara Rheault

TR

Statistics

Publications

21

Citations

1.2K

H-Index

16

Active since

2000

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

North Dakota State University

South Texas Veterans Health Care System

University of Alabama at Birmingham

Tara Rheault is an author at Research Triangle Park Foundation specializing in pharmacology, chemistry, and medicine.

Publications per year

2000–2025

21

Publications

21

Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors

Tara Rheault, John Stellwagen, George M. Adjabeng et al. · ACS Medicinal Chemistry Letters · 2013 · 258 citations · Full text

Medicine, Oncology, Pharmacology +17

Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions

Alastair J. King, Marc R. Arnone, Maureen R. Bleam et al. · PLoS ONE · 2013 · 217 citations · Full text

Medicine, Oncology, Pharmacology +16

Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials)

Antonio Anzueto, Igor Barjaktarević, Thomas M. Siler et al. · American Journal of Respiratory and Critical Care Medicine · 2023 · 146 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors

Tara Rheault, Thomas R. Caferro, Scott H. Dickerson et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 83 citations · Full text

Medicine, Medicinal Chemistry, Oncology +9

Enantioselective Conjugate Radical Addition to β‐Acyloxy Acrylate Acceptors: An Approach to Acetate Aldol‐Type Products

Mukund P. Sibi, Jake R. Zimmerman, Tara Rheault · Angewandte Chemie International Edition · 2003 · 57 citations

Natural Sciences, Chemistry, Biocatalysis +9

1–5 of 21